Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrea Pascual Oliver
Observed names:
A Pascual Oliver,
Andrea Pascual-Oliver
Institution:
Hospital Universitario Miguel Servet
Observed institutions:
Hospital Universitario Miguel Servet,
Instituto de Investigación Sanitaria Aragón,
Instituto Aragonés de Ciencias de la Salud
ORCID:
0000-0002-6811-7702
Observed ORCID:
0000-0002-6811-7702
OpenAlex ID:
A5066853305
MASLD-Related Hepatocarcinoma: Special Features and Challenges
2024
·
Carmen Yagüe-Caballero
, Diego Casas-Deza
, et al.
·
Journal of Clinical Medicine
·
20
HLA-DQA1*05 Was Not Associated With Primary Nonresponse or Loss of Response to First Anti-TNF in Real-World Inflammatory Bowel Disease Patients
2023
·
Andrea Pascual-Oliver
, Diego Casas-Deza
, et al.
·
Inflammatory Bowel Diseases
·
19
Patients Included in Clinical Trials of Biological Drugs for Inflammatory Bowel Disease Do Not Represent the Real-World Population
2025
·
Diego Casas Deza
, Cristina Larrubia Domínguez
, et al.
·
The American Journal of Gastroenterology
·
16
Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication
2024
·
Andrea Pascual-Oliver
, Diego Casas-Deza
, et al.
·
Pathogens
·
9
PDF
Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCU
2025
·
Esteban Fuentes-Valenzuela
, Iria Bastón-Rey
, et al.
·
Journal of Crohn s and Colitis
·
3
P-31 - Los Pacientes Incluidos En Los Ensayos Clínicos De Autorización De Los Fármacos Biológicos Para La Enfermedad Inflamatoria Intestinal No Representan a La Población Real
2025
·
Diego Casas Deza
, Cristina Larrubia Domínguez
, et al.
·
Gastroenterología y Hepatología
P949 Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study. A multicenter study from the young group of GETECCU
2024
·
E Fuentes-Valenzuela
, I Bastón-Rey
, et al.
·
Journal of Crohn s and Colitis
PDF
68 - Papel Del Hla Dqa1*05 En La Respuesta a Tratamiento Biológico Con Anti-tnf En Pacientes Con Enfermedad Inflamatoria Intestinal
2023
·
Andrea Pascual Oliver
, Camila Cuaran Cetina
, et al.
·
Gastroenterología y Hepatología
PDF
55 - Impacto De La Mesalazina En La Respuesta a La Vacunación Contra El Covid-19 En Pacientes Con Enfermedad Inflamatoria Intestinal. Resultados De Un Estudio Prospectivo Multicéntrico De Geteccu (vacoveii)
2023
·
Ana Belén Julián Gomara
, Diego Casas Deza
, et al.
·
Gastroenterología y Hepatología
PDF
P627 HLA DQA1*05 was not associated to primary non-response or loss of response to first anti-TNF in real world Inflammatory Bowel Disease patients.
2023
·
A Pascual Oliver
, C Cuarán
, et al.
·
Journal of Crohn s and Colitis
PDF
Show more works
View as search
Works count:
10
Citation count:
67
H-index:
4
I10-index:
3
Year
Topic
Type